Pharmaceutical - Anti-virals


Current filters:


Popular Filters

226 to 250 of 307 results

UK to implement child flu vaccines program


UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…


More than 150 ARVs available through PEPFAR for global HIV/AIDS relief


US Food and Drug Administration Commissioner Margaret Hamburg says that the agency has approved or tentatively…


Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa


USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination


Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases…


US govt plans innovative public-private partnerships to turn the tide in fight against HIV/AIDS


In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012) in Washington…

Anti-viralsBiotechnologyHealthcareNorth AmericaPharmaceutical

Domestic HIV funding outpaces international investments


A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…


Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season


The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

FDA approves Truvada, first drug for reducing the risk of sexually acquired HIV infection


Despite protests from consumer groups such as the AIDS Healthcare Foundation (AHF), the US Food and Drug…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

J&J'S rilpivirine also proven for combination HIV product, says IQWiG


Since the start of 2012, a new drug - rilpivirine from US health care giant Johnson & Johnson (NYSE:…

Anti-viralsEuropeEvipleraJohnson & JohnsonPharmaceuticalPricingRegulationrilpivirine

Antivirals market facing generics threat, especially for HIV drugs


Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in…

Anti-viralsGenericsMarkets & MarketingPatentsPharmaceutical

Latin America progress and challenges in expanding access to HIV treatment highlighted by PAHO


A number of countries in Latin America and the Caribbean - including Argentina, Brazil, Chile, Cuba,…

Anti-viralsBiotechnologyHealthcarePharmaceuticalSouth America

Incivek and Victrelis important advances in HCV, but still unmet needs


Nearly two-thirds of US surveyed physicians have seen an increase in the hepatitis C (HCV) patients they…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

Teva gets rights to BioAlliance's Sitavig in Israel


French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Incivek and Victrelis have collectively penetrated over three-quarters of the US genotype 1 HCV market


One year post launch, Vertex's (Nasdaq: VRTX) Incivek (telaprevir) and Merck & Co (NYSE: MRK) and Roche's…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

Scientists report new approach to attack flu virus


An international research team has manufactured a new protein that can combat deadly flu epidemics. The…


Tanzanian drugmaker to start producing ARVs in August


Tanzania Pharmaceutical Industries (TPI) was due to start productions earlier this year, but finalization…

Anti-viralsGenericsMarkets & MarketingPharmaceuticalRest of the WorldTanzania Pharma Industries

US House of Representatives trumps Administration on Global AIDS budgets


The US House of Representatives has budgeted $193 million more to global AIDS programs in the 2013 Foreign…

Anti-viralsFinancialHealthcareNorth AmericaPharmaceuticalPolitics

All "baby boomers" should be tested once for hepatitis C, says USA's CDC


On the eve of the first ever National Hepatitis Testing Day (May 19), the US Centers for Disease Control…

Anti-viralsHealthcareNorth AmericaPharmaceuticalRegulation

US FDA fast-tracks Achillion's hepatitis C drug candidate


USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) says it has received Fast Track designation from the…

Achillion PharmaceuticalsAnti-viralsNorth AmericaPharmaceuticalRegulation

FDA advisory thumbs up for Gilead's once-daily Quad for HIV


There was more good news for Gilead Sciences (Nasdaq: GILD), the world's largest maker of HIV drugs,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalQuadRegulation

226 to 250 of 307 results

Back to top